The Scientist

» clinical trials and microbiology

Most Recent

In two early trials, vaccines tailored to the mutations in individuals’ cancers appeared to protect 12 of 19 patients against relapse. 

1 Comment

The discovery of peptides, enzymes, and other gene products that confer antibiotic resistance could give clues to how it develops.

1 Comment

image: ASM to Discontinue Small Conferences

ASM to Discontinue Small Conferences

By | June 6, 2017

Numerous scientists are disappointed with the American Society for Microbiology’s decision, and some are hatching plans to keep the meetings alive.

0 Comments

image: Opinion: The Virome and the Anti-vaccination Debate

Opinion: The Virome and the Anti-vaccination Debate

By | June 6, 2017

Advances in microbiome research are increasingly used in anti-vaccination arguments, yet the science actually undermines the premise of the argument.

7 Comments

A new screening tool flags dozens of papers with potential errors.

0 Comments

Lactobacillus parafarraginis metabolites hindered the growth of multiple, distantly related bacterial pathogens. 

0 Comments

The publicly available database found nearly a third of samples included mutations targeted by either approved drugs or therapies in clinical trials. 

0 Comments

Researchers are beginning to uncover a link between activity level and the microbial makeup of one’s gut.

0 Comments

image: Researchers Discover Salt-Loving Methanogens

Researchers Discover Salt-Loving Methanogens

By | May 26, 2017

Two previously overlooked archaeal strains fill an evolutionary gap for microbes.

2 Comments

image: Opinion: Token Pharmacovigilance

Opinion: Token Pharmacovigilance

By | May 23, 2017

A US government website for collecting reports of side effects associated with vaccines is broken. Why has no one noticed?

4 Comments

Popular Now

  1. A Newly Identified Species Represents Its Own Eukaryotic Lineage
  2. Man Receives First In Vivo Gene-Editing Therapy
  3. Telomere Length and Childhood Stress Don’t Always Correlate
  4. Optogenetic Therapies Move Closer to Clinical Use
RayBiotech